The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive regression and memory loss. Dysfunctions of both glucose metabolism and mitochondrial dynamics have been recognized as the main upstream events of the degenerative processes leading to AD. It has been rec...
Main Authors: | Simona Magi, Alessandra Preziuso, Silvia Piccirillo, Francesca Giampieri, Danila Cianciosi, Monia Orciani, Salvatore Amoroso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/8/2109 |
Similar Items
-
Gateways for Glutamate Neuroprotection in Parkinson’s Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD
by: Silvia Piccirillo, et al.
Published: (2020-09-01) -
The Mitochondrial Carnitine Acyl-carnitine Carrier (SLC25A20): Molecular Mechanisms of Transport, Role in Redox Sensing and Interaction with Drugs
by: Annamaria Tonazzi, et al.
Published: (2021-03-01) -
Neuroprotective Effects of Pre-Treament with l-Carnitine and Acetyl-l-Carnitine on Ischemic Injury In Vivo and In Vitro
by: Shunjiang Xu, et al.
Published: (2012-02-01) -
Neuroprotective effects of L-carnitine against oxygen-glucose deprivation in rat primary cortical neurons
by: Yu Jin Kim, et al.
Published: (2012-07-01) -
Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation
by: Paolo Gadioli La Guardia, et al.
Published: (2013-05-01)